AnRes Clinical

AnRes Clinical

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

AnRes Clinical is a private, revenue-generating consultancy firm founded in 2015, specializing in clinical development services for biotech sponsors. With a team of approximately 25 consultants, the company acts as an embedded partner, offering deep therapeutic and operational expertise to navigate the complexities of global clinical trials from design through regulatory submission. Its business model is purely service-based, focusing on mitigating development risks for small to mid-sized biotech companies without large internal teams.

OncologyAutoimmune DiseasesRare DiseasesNeurology

Technology Platform

Integrated clinical development consultancy model leveraging deep therapeutic expertise (oncology, autoimmune, rare diseases, neurology) and a partner-embedding service approach to de-risk biotech trials. Utilizes operational and regulatory knowledge as its core platform.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

Growing demand from virtual/small biotechs needing embedded clinical expertise.
Increasing trial complexity and regulatory scrutiny in core therapeutic areas like oncology and rare diseases.
Potential to expand service offerings into adjacent areas like digital health integration and real-world evidence.

Risk Factors

Revenue is highly dependent on the funding cycle and pipeline success of biotech clients, creating cyclical demand.
Intense competition from both large CROs and niche consultancies.
Operational risk tied to talent retention and the performance of client trials.

Competitive Landscape

Competes with large global Contract Research Organizations (CROs) that offer strategic consulting arms, as well as numerous boutique clinical and regulatory consultancies. Differentiation is based on deep therapeutic expertise, a true partnering mindset, and a focus on acting as an embedded extension of the sponsor's team rather than an external vendor.